W Murmann is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology.
According to data from OpenAlex, W Murmann has authored 38 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in W Murmann's work include Synthesis and Characterization of Heterocyclic Compounds (5 papers), Synthesis and Reactions of Organic Compounds (5 papers) and Synthesis of Organic Compounds (5 papers). W Murmann is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (5 papers), Synthesis and Reactions of Organic Compounds (5 papers) and Synthesis of Organic Compounds (5 papers). W Murmann collaborates with scholars based in Italy, Japan and China. W Murmann's co-authors include L Almirante, A Gamba, Pierluigi Rugarli, I Setnikar, M Magistretti, Paolo Da Re, P Schiantarelli, John Hidalgo, Alessandro Subissi and G Bramanti and has published in prestigious journals such as Nature, Endocrinology and Journal of Medicinal Chemistry.
In The Last Decade
W Murmann
36 papers
receiving
577 citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Derivatives of Imidazole. I. Synthesis and Reactions of Imidazo[1,2-α]pyridines with Analgesic, Antiinflammatory, Antipyretic, and Anticonvulsant Activity
1965271 citationsL Almirante, Pierluigi Rugarli et al.Journal of Medicinal Chemistryprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of W Murmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Murmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Murmann more than expected).
This network shows the impact of papers produced by W Murmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Murmann. The network helps show where W Murmann may publish in the future.
Co-authorship network of co-authors of W Murmann
This figure shows the co-authorship network connecting the top 25 collaborators of W Murmann.
A scholar is included among the top collaborators of W Murmann based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with W Murmann. W Murmann is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Hermanns, W., et al.. (1985). [Lymphatic leukosis in a boar].. PubMed. 92(7-8). 280–3.1 indexed citations
2.
Murmann, W, et al.. (1984). [Pathology of marine mammals].. PubMed. 12(1). 105–15.5 indexed citations
Schiantarelli, P & W Murmann. (1980). Antispasmodic activity of rociverine on the smooth musculature of the urinary tract. Comparative in vitro study.. PubMed. 30(7). 1102–9.2 indexed citations
5.
Subissi, Alessandro, Mark Biagi, & W Murmann. (1980). Some aspects of sorbinicate pharmacokinetics.. PubMed. 30(8). 1278–84.1 indexed citations
6.
Schiantarelli, P, W Murmann, & Simona Magi. (1979). Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions.. PubMed. 29(5). 760–5.5 indexed citations
7.
Schiantarelli, P, et al.. (1978). Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity.. PubMed. 28(7). 1130–42.3 indexed citations
8.
Schiantarelli, P, et al.. (1978). Polyvalent antiinflammatory activity of a polyanionic fraction of bovine pancreas. Potential value in the treatment of atherosclerosis.. PubMed. 28(7). 1146–53.2 indexed citations
9.
Almirante, L, et al.. (1971). [Imidazole derivatives. V. Synthesis and pharmacological activity of alkyl derivatives of imidazo-(1,2-a)-pyridine].. PubMed. 110(6). 317–21.1 indexed citations
Murmann, W, et al.. (1969). [The dwarf pig, a new means of pharmacologic research. I. Its use in the study of a drug with beta adrenergic blocking action (INPEA)].. PubMed. 108(2). 108–18.1 indexed citations
Almirante, L, et al.. (1966). Chloroform-water partition and other physical characteristics of 8 different adrenergic beta-receptor blocking drugs.. PubMed. 105(11). 816–9.3 indexed citations
15.
Murmann, W & A Gamba. (1966). [Pharmacological properties of 1-(4'-nitrophenyl)-2-isopropylamino-ethanol (INPEA), a new beta-adrenergic receptor antagonist. I. Effects on arterial blood pressure].. PubMed. 105(3). 203–16.3 indexed citations
Setnikar, I, et al.. (1961). The coronary vasodilator activity of morpholinoethyl-3-methyl-flavone-8-carboxylate in comparison with that of other coronary vasodilators.. PubMed. 131. 187–208.2 indexed citations
18.
Setnikar, I, W Murmann, & M Magistretti. (1961). Pneumocinetic activity of 3-methyl-7-methoxy-8-dimethylamino-methylflavone-HCl (dimefline),2,3-dimethyl-7-methoxy-8-morpholinomethyl-chromone-HCl, and some other central nervous system stimulants.. PubMed. 11. 1109–19.4 indexed citations
Setnikar, I & W Murmann. (1958). [Pharmacological data on p-hydroxypropiophenone sulfate].. PubMed. 13(8). 541–60.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.